Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19: grading of evidence - evidence to recommendation tables, first issued 14 January 2021 (included in the background document), updated 15 June 2021, updated 19 November 2021, updated 21 January 2022